PRL3 as a therapeutic target for novel cancer immunotherapy in multiple cancer types
Sign Up to like & getrecommendations! Published in 2023 at "Theranostics"
DOI: 10.7150/thno.79265
Abstract: Phosphatase of Regenerating Liver-3 (PRL3) was discovered in 1998 and was subsequently found to be correlated with cancer progression and metastasis in 2001. Extensive research in the past two decades has produced significant findings on… read more here.
Keywords: prl3; immunotherapy; cancer types; multiple cancer ... See more keywords